We sincerely apologize for being unable to host the scheduled Twitter Space today.
Due to unforeseen operational and technical issues, the session was halted. We regret any inconvenience this may have caused our anticipated audience.
The issues implicated have since been identified and fully resolved. We are committed to ensuring a smooth and hitch-free experience in future sessions.
Its tonight. It will be interesting. It will be deep.
@ajibola_ai5648, @MorganS45287519 and @AEmmanuelRN are joining us for an eventful conversation.
Be there!
Please Join this big movement!
*Share, Schedule, Engage!*
We don't just need you on this conversation, we need all nurses!
Repost with your full energy. The conversation is going to be hot!
We're starting a new movement. Its big, interesting, and empowering. Every nurse, from the bedside carer to the education juggernauts, every stakeholder in this profession is crucial to this movement.
So please, you're important to the Sunday X-space. You'd listen to varied perspectives on the subject matter. You'd contribute significantly to the subject. All contributions would be validated, all suggestions implemented.
The real threat to professional harmony lies not in the policy itself, but in the resistance to acknowledging evolving professional roles in line with global best practices.
Similarly, in the United States, their involvement in collaborative drug therapy management has been associated with improved clinical outcomes and cost savings.
This assertion misrepresents the objective and impact of the Consultant Pharmacist Cadre. Rather than posing a threat, Consultant Pharmacists enhance patient safety, improve therapeutic outcomes, and strengthen interdisciplinary, patient-centered care.
1. “Let it be stated in no uncertain terms: *This policy, if allowed to stand, poses grave threats to professional harmony, patient safety, and the sanctity of the healthcare delivery framework.”*
In response to the press release issued by the Nigerian Medical Association (NMA) Lagos State Chapter, dated 18th April 2025, titled *“Information on the Implementation of Consultant Pharmacist Cadre”*, I would like to address a few critical points as follows: